Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fai...
“A credit freeze is one of the most effective ways to safeguard against financial fraud, especially in the wake of cyberattacks and data breaches,” said Susan Espinosa, vice president of member experience atSkyla Federal Credit Union. “If a hacker gains access to personal information, the...
Crispr stock is tumbling for the fifth straight week as the top Cathie Wood's holding struggles amid dimming expectations for its new Vertex-partnered gene-editing drug. Crispr Therapeutics (CRSP) and Vertex Pharmaceuticals (VRTX) gained Food and Drug Administration approval for Casgevy on Dec. ...
Overall, the stock has an aggregate VGM Score of F. If you aren't focused on one strategy, this score is the one you should be interested in. Outlook Estimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. It's no sur...